Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 17 (RPS29P17) is a processed pseudogene related to the functional RPS29 gene, which encodes a small ribosomal subunit protein involved in protein synthesis[3][4]. RPS29P17 does not code for a functional protein and has no known biological, pathological, or therapeutic relevance. Pseudogenes such as RPS29P17 are common for ribosomal protein genes and typically arise as non-functional genomic copies through evolutionary duplication events[3][4]. RPS29P17 is a non-coding pseudogene, not a functional protein or druggable target[3][4]. There is no evidence implicating RPS29P17 in disease, therapy, or as a biological marker. Its only relevance is as part of the extensive human ribosomal protein pseudogene repertoire.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein S29 pseudogene 17 (RPS29P17).